The Economic Dimension of Obesity Treatment Obesity imposes an enormous economic burden — both on individual patients through elevated healthcare costs, and on the broader healthcare system through the enormous disease burden of obesity-related comorbidities. US adults with obesity spend an average of $1,861 more in annual medical costs than . . . Read more
Obesity as a Chronic Disease: The Medical Framework for Phentermine Therapy The evolution in medical understanding of obesity — from a lifestyle problem requiring personal willpower to a chronic, relapsing neurobiological disease requiring sustained medical treatment — is the essential conceptual foundation for understanding why phentermine therapy, when properly indicated . . . Read more
Introduction: Phentermine and Its Role in Obesity Medicine Phentermine is the most widely prescribed weight-loss medication in the United States and one of the most studied anti-obesity pharmacological agents in clinical history. Since its FDA approval in 1959, phentermine has helped millions of patients with obesity achieve clinically meaningful weight . . . Read more